Global Smart Inhalers Market

The global smart inhalers market is projected to register a robust CAGR during the forecast period, between 2021 and 2028. Smart inhalers are gadgets that are used to administer medication by inhalation. For the prevention and treatment of respiratory disorders such as chronic obstructive pulmonary disease and asthma, inhalers contain glucocorticoids, anticholinergic, beta-agonists, and insulin. These inhalers are referred to as smart inhalers as sensors are linked to the inhalers, which monitor the correct dose per intake and the technique employed for inhaling the drug.

To track the patient's inhaler consumption, the sensor's data is shared with the healthcare experts and the patient. The monitored data is then communicated with their mobile apps through platform such as Hailie using Bluetooth technology. Hailie systems are detectors that are fitted to inhalers and share data through the operating system to track their adherence and health rate.

Get Free Sample Report

Market Trends, Drivers, Restraints, and Opportunities

• Rising prevalence of respiratory illnesses such as COPD and asthma drives the market expansion.
• Technological improvement in the creation of better smart inhaler systems and devices is estimated to spur the market growth.
• Growing collaboration between digital health and pharmaceutical companies is estimated to drive the market.
• The lack of understanding about symptoms of COPD and asthma is projected to limit the growth of the market.
• The presence of alternative manual inhalers and e high costs of smart inhalers are projected to hinder market expansion throughout the projection period.
• Increasing use of smart inhalers for direct drug administration to the respiratory system is expected to drive market growth.

Scope of Smart Inhalers Market Report

The report on the smart inhalers market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.

Smart Inhalers Market Segment Insights

Dry powder inhaler (DPI)-based smart inhalers segment is projected to hold significant market share

Based on products, the smart inhalers market can be bifurcated into metered dose inhaler (MDI)-based smart inhalers and dry powder inhaler (DPI)-based smart inhalers. The DPI-based smart inhalers include add-on sensors produced by digital firms to interface with dry powder inhalers manufactured by pharmaceutical companies.

DPI is a device that delivers medicine to the lungs in the form of a powder form rather than using a chemical accelerator to force the medication out from the device. DPI dispenses the medication based on the patient's inhaling capacity. Multiple-dose devices are present that can carry up to 200 doses. Rising frequency of chronic respiratory diseases around the world is expected to maintain a consistent growth of the market segment.

Get Free Sample Report

Asthma segment is anticipated to account for a substantial share

On the basis of disease indications, the market can be divided into asthma and chronic obstructive pulmonary disease. The asthma segment is anticipated to account for a substantial share due to the growing prevalence of asthma over the world. Asthma is one of the most common chronic inflammatory airway illnesses. The COPD segment is estimated to expand at a robust pace in the coming years due to the rising prevalence of COPD. It is a chronic lung condition that impairs airflow. The segment's rapid rise can be attributed to the increased use of smart inhalers for illness monitoring on a regular basis.

Hospital pharmacies segment to register a substantial growth rate during the forecast period

In terms of distribution channels, the smart inhalers market can be segmented into hospital pharmacies, online pharmacies, and retail pharmacies. The hospital pharmacies segment is anticipated to expand a substantial growth rate during the forecast period. Patients receiving hospital treatment have easy access to hospital pharmacies.

Furthermore, hospital pharmacists have excellent relationships with smart inhaler distributors. As a result, the aforementioned reasons point to a healthy growth path for the hospital pharmacies segment. Furthermore, the government's rising initiatives to integrate smart medical equipment in such settings can drive  the segment growth.

Get Free Sample Report

Asia Pacific is expected to dominate the market

In terms of regions, the market can be categorized as Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. Asia Pacific is expected to dominate the market owing to the growing healthcare costs as well as an increase in product development in India and China. The market in North America is estimated to expand at a robust pace in the coming years.

Get Free Sample Report

Segments

By Products

• Metered Dose Inhaler (MDI)-based smart inhalers
• Dry Powder Inhaler (DPI)-based smart inhalers

By Disease Indications

• Asthma
• Chronic Obstructive Pulmonary Disease

By Distribution Channels

• Hospital Pharmacies
• Online Pharmacies
• Retail Pharmacies

By Regions

• Asia Pacific
• North America
• Latin America
• Europe
• Middle East & Africa

By Key Players

• Boehringer Ingelheim
• H&T Presspart Manufacturing Ltd.
• Aptar Pharma
• Cohero Health, Inc.
• Findair Sp. z o. o.
• Vectura Group
• GlaxoSmithKline
• Propeller Health
• Zeolr Technologies Pvt Ltd

Competitive Landscape

Key players in the smart inhalers market are Boehringer Ingelheim, H&T Presspart Manufacturing Ltd., Aptar Pharma, Cohero Health, Inc., Findair Sp. z o. o., Vectura Group, GlaxoSmithKline, Propeller Health, and Zeolr Technologies Pvt Ltd. These players have actively engaged in several market development activities including collaborations, agreements, mergers & acquisitions, production capacity expansion, new product launches, and partnerships to increase their market share.